Risk sharing agreements soar as market access risk increases
Pharmaceutical Technology
MARCH 17, 2023
These agreements have been particularly propelled by the recent rise in inflationary pressures and pharmaceutical market instability, pushing healthcare systems to find new ways to reduce risks associated with new drugs. In some cases, she said, “[drug] innovation would have been otherwise hindered by their price tag alone”.
102 
Let's personalize your content